Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
$35.41M
Dr. Shalabh K. Gupta M.D., MPA
9.00
Los Altos, CA
Jul 13, 2021
-1.04
$-0.36
1.22
1.42
-2,452.71%
-0.19
0.00
1.12
10.73
1.22
-174.28%
-741.73%
Similar stocks (2)
Cardio Diagnostics Holdings, Inc.
CDIO
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.00268%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (2)
Cardio Diagnostics Holdings, Inc.
CDIO
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.00268%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%